http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54f6f14c9c407ce81ecbd1bf2fde271e
Outgoing Links
Predicate | Object |
---|---|
family-name | Coxon |
name | Angela Coxon |
given-name | Angela |
organization-name | Amgen Incorporated, One Amgen Center Drive, Thousand Oaks, California 91320, United States 6Oncology Research, Amgen Research, Thousand Oaks, California. 1Departments of Oncology Research, Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 Authors' Affiliations: 1Premiere Oncology of Arizona, Scottsdale, Arizona; 2Indiana University School of Medicine, Indianapolis, Indiana; 3University of Colorado Cancer Center, Aurora, Colorado; and 4Amgen Inc., Thousand Oaks, California Amgen Inc., Thousand Oaks, California. Amgen Inc. Chemistry Research and Discovery, Cambridge, Massachusetts 02139, and Thousand Oaks, California 91320 7Oncology Research, Amgen Inc., Thousand Oaks, California. 1Amgen Discovery Research, Thousand Oaks, California. Authors' Affiliations: 1Oncology Research, 2Protein Science, 3Clinical Immunology, and 4High Throughput Screening-Molecular Pharmacology, Amgen Inc., Thousand Oaks, California; 5Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, California; and 6Laboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland 1Oncology Research, Amgen Research, Thousand Oaks, California. Center for Blood Research, Department of Pathology, and Brigham and Womens’ Hospital, Harvard Medical School, Boston, MA 02115 Authors' Affiliations: 1Cardiovascular Research Institute, Comprehensive Cancer Center, and Department of Anatomy, University of California, San Francisco, California and 2Oncology Research, Amgen, Inc., Thousand Oaks, California Departments of Oncology Research, Protein Sciences, and Clinical Immunology, Amgen, Inc., Thousand Oaks, California Authors' Affiliations: 1Department of Pediatric Oncology, and 2Center for Sarcoma and Bone Oncology, Ludwig Center for Cancer Research, Dana-Farber Cancer Institute; 3Division of Hematology/Oncology, Department of Medicine, Children's Hospital Boston; 4Harvard Medical School, Boston, Massachusetts; 5Departments of Pediatrics and Genetics, Lineberger Comprehensive Cancer Center, North Carolina Children's Hospital, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; and 6Department of Oncology Research, Amgen, Inc., Thousand Oaks, California 2Amgen Research, Thousand Oaks, California.; 3Department of Oncology-Immunology Research, Amgen, South San Francisco and Amgen Thousand Oaks, California. Authors' Affiliation: Department of Oncology Research, Amgen, Inc., Thousand Oaks, California 1Department of Oncology Research, Amgen Inc., Thousand Oaks, California. 2Department of Oncology Research, Amgen, Thousand Oaks, California. Departments of Medicinal Chemistry, Molecular Pharmacology, and Molecular Structure, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139-1581, and Departments of Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 5Department of Cancer Biology, Amgen, Inc., Thousand Oaks, California Department of Medicinal Chemistry, Department of Molecular Structure, and Department of Pharmacokinetics and Drug Metabolism, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of Oncology Research, Department of Toxicology, and Department of Pharmaceutics, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320 Amgen Research, Amgen Inc., Thousand Oaks, CA 1Oncology Research, Departments of Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 3Department of Oncology Research, Amgen Inc., Thousand Oaks, California. From the Department of Anesthesia, Children’s Hospital, Boston (S.G.S., P.R.H.), and CNS Research Institute and Department of Neurosurgery (Y.F.W., S.A.L.) and Department of Pathology (A.C., M.P.F., T.M.N.), Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass. Dr Soriano and Dr Coxon contributed equally to this work. 1Oncology Research, Amgen Inc., Thousand Oaks, California.; 2Amgen Research, Amgen Inc., Thousand Oaks, California. Departments of 1Oncology Research, 2Pharmacokinetics and Drug Metabolism, and 3Pathology, Amgen Inc., Thousand Oaks, California; 4Department of Oncology, Amgen Inc., Seattle, Washington; Comparative Ophthalmic Research Laboratories, University of Wisconsi 5Amgen Research Munich GmbH, Munich, Germany. 1Laboratory of Molecular Oncology, 2Laboratory of Antibody Technology, and 3Laboratory of Computational Biology, Van Andel Research Institute, Grand Rapids, Michigan; and 4Amgen, Inc., Thousand Oaks, California, Department Oncology Research aDepartment of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115 7Oncology Research, Amgen Research, Thousand Oaks, California, USA. Departments of Hematology and Oncology, Authors' Affiliations: 1Department of Human Oncology, Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; 2Department of Radiation Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands; 3Department of Oncology Research, Amgen Inc., Thousand Oaks, California; and 4Amgen Inc., Seattle, Washington *Pathology and ‡Department of Pathology, Brigham and Women’s Hospital, Boston, MA 02115; and Authors' Affiliations: Departments of 1Oncology Research, 2Comparative Biology and Safety Sciences, 3Protein Science, and 4Pharmacokinetics and Drug Metabolism, Amgen, Inc., Thousand Oaks, California; and 5Cardiovascular Research Institute, Comprehensive Cancer Center, and Department of Anatomy, University of California, San Francisco, California Departments of Medicinal Chemistry, Molecular Pharmacology, and Molecular Structure, Amgen Inc., One Kendall Square, Bldg. 1000, Cambridge, Massachusetts 02139; Departments of Molecular Pharmacology, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320 2Oncology Research, Amgen Inc., Thousand Oaks, California. Department of Oncology Research, Amgen, Inc., Thousand Oaks, CA, USA |
Incoming Links
Showing number of triples: 1 to 116 of 116.